Study results show that patients diagnosed with rheumatoid arthritis and who are either significantly underweight or overweight/obese have lower sustained remission rates compared with their normal weight counterparts.
A “biosimilar” form of etanercept is clinically equivalent to the branded form for rheumatoid arthritis, according to data presented at the 2014 annual meeting of the American College of Rheumatology.
A blood test may offer a reliable way to identify rheumatoid arthritis patients who are unlikely to respond to anti-tumor necrosis factor-alpha inhibitors, speeding treatment with other drugs and lowering costs.
Women using intrauterine devices with a family history of rheumatoid arthritis are at greater risk for the condition.
Administration of the varicella zoster vaccine is safe in patients with rheumatoid arthritis or other rheumatic conditions who are taking biologic disease-modifying anti-rheumatic drugs, according to study results presented at the 2014 American College of Rheumatology annual meeting.
Adjusting treatment to maintain tight control of disease-related disability reduces mortality in rheumatoid arthritis, according to new research presented at the 2014 American College of Rheumatology annual meeting.